Department of Nursing , Chang Gung University of Science and Technology, Taoyuan, Taiwan.
Alcohol Clin Exp Res. 2014 Jan;38(1):44-50. doi: 10.1111/acer.12215. Epub 2013 Aug 1.
It has been well documented that a variant allele of mitochondrial aldehyde dehydrogenase 2 (ALDH2), ALDH2*2, commonly occurs in East Asians but rarely in other ethnic populations. This unique allelic variation significantly influences drinking behavior and susceptibility to development of alcoholism. Previous structural, functional, and cellular studies indicate that the resulting variant polypeptide subunit K (Lys-487) exerts dominance of null activity and shorter half-life over the tetrameric enzyme molecules in distinct manners. However, the in vivo evidence for the proposed dominance mechanisms remains lacking.
To address this question, we investigated 33 surgical liver samples identified to be normal homozygous ALDH2*1/1 (n = 17), heterozygous ALDH21/2 (n = 13), and variant homozygous ALDH22/*2 (n = 3). The ALDH2 activity was determined at a sufficient low acetaldehyde concentration (3 μM) and the isozyme protein amount by immunotitration using purified class-specific antibodies.
The tissue ALDH2 activity in heterozygotes was 17% that of the ALDH2*1/1 genotype (p < 0.001), whereas the activity of ALDH22/2 was too low to be precisely determined. The protein amounts of tissue ALDH2 in variant homozygotes and heterozygotes were similar but only 30 to 40% that of normal homozygotes (p < 0.01). Linear regression analyses show that ALDH2 activities were significantly correlated with the protein contents in normal homozygotes and heterozygotes, respectively (p < 0.005). The specific activity of ALDH2 per enzyme protein in ALDH21/2 was 38% that of ALDH21/*1 (p < 0.001).
These results are in good agreement with those predicted by the model studies, thus providing in vivo evidence for differential impairments of hepatic acetaldehyde oxidation with alcohol metabolism in individuals carrying ALDH2*1/2 and ALDH22/*2 genotypes.
线粒体乙醛脱氢酶 2(ALDH2)的变异等位基因 ALDH2*2 常见于东亚人群,但在其他种族中很少见。这种独特的等位基因变异显著影响饮酒行为和酗酒易感性。先前的结构、功能和细胞研究表明,由此产生的变异多肽亚基 K(Lys-487)以不同的方式对四聚体酶分子产生无效活性和较短半衰期的优势。然而,对于所提出的优势机制的体内证据仍然缺乏。
为了解决这个问题,我们研究了 33 个手术肝脏样本,这些样本被鉴定为正常纯合子 ALDH2*1/1(n = 17)、杂合子 ALDH21/2(n = 13)和变异纯合子 ALDH22/*2(n = 3)。在足够低的乙醛浓度(3 μM)下测定 ALDH2 活性,并通过使用纯化的类特异性抗体进行免疫滴定来测定同工酶蛋白量。
杂合子的组织 ALDH2 活性为 ALDH2*1/1 基因型的 17%(p < 0.001),而 ALDH22/2 的活性太低,无法精确测定。变异纯合子和杂合子组织 ALDH2 的蛋白量相似,但仅为正常纯合子的 30%至 40%(p < 0.01)。线性回归分析表明,ALDH2 活性与正常纯合子和杂合子的蛋白含量分别显著相关(p < 0.005)。ALDH21/2 中每个酶蛋白的 ALDH2 比活性为 ALDH21/*1 的 38%(p < 0.001)。
这些结果与模型研究的预测结果非常吻合,从而为携带 ALDH2*1/2 和 ALDH22/*2 基因型的个体中酒精代谢的肝乙醛氧化功能差异受损提供了体内证据。